PLATELET-INHIBITING DRUGS IN PREVENTION OF CLINICAL THROMBOTIC DISEASE .3.

被引：99

作者：

GENTON, E

GENT, M

HIRSH, J

HARKER, LA

机构：

[1] UNIV COLORADO,MED CTR,DEPT MED,4200 E 9TH AVE,DENVER,CO 80220

[2] MCMASTER UNIV,MED CTR,DEPT PATHOL,HAMILTON,ONTARIO,CANADA

[3] MCMASTER UNIV,MED CTR,DEPT MED & CLIN EPIDEMIOL,HAMILTON,ONTARIO,CANADA

[4] MCMASTER UNIV,MED CTR,DEPT BIOSTATISTICS,HAMILTON,ONTARIO,CANADA

[5] UNIV WASHINGTON,HARBORVIEW MED CTR,SCH MED,DEPT MED,DIV HEMATOL,SEATTLE,WA 98105

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1975年 / 293卷 / 25期

关键词：

D O I：

10.1056/NEJM197512182932506

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1296 / 1300

页数：5

共 21 条

[1]

[Anonymous], 1972, Lancet, V2, P441

[2]

BROWSE NL, 1969, LANCET, V2, P718

[3] FIBRINOGEN-DETECTABLE THROMBOSIS IN LEGS AND PULMONARY-EMBOLISM [J].

BROWSE, NL ;

CLEMENSON, G ;

CROFT, DN .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 1 (5908) :603-604

[4] PREVENTION OF POSTOPERATIVE DEEP VENOUS THROMBOSIS IN LEGS BY ORALLY-ADMINISTERED HYDROXYCHLOROQUINE SULFATE [J].

CARTER, AE ;

EBAN, R .

BRITISH MEDICAL JOURNAL, 1974, 3 (5923) :94-95

[5] PREVENTION OF POSTOPERATIVE DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM [J].

CARTER, AE ;

EBAN, R ;

PERRETT, RD .

BRITISH MEDICAL JOURNAL, 1971, 1 (5744) :312-&

[6]

CLAGETT G P, 1974, Surgical Forum (Chicago), V25, P473

[7]

Evans~ G, 1975, PLATELETS DRUGS THRO, P258, DOI 10.1159/000395715

[8] SURGICAL CONDITIONS AS RISK FACTORS IN DEVELOPMENT OF VENOUS THROMBOSIS [J].

FREIMAN, DG .

MILBANK MEMORIAL FUND QUARTERLY, 1972, 50 (01) :60-67

[9] COMPARISON OF WARFARIN, LOW-MOLECULAR-WEIGHT DEXTRAN, ASPIRIN, AND SUBCUTANEOUS HEPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP-REPLACEMENT [J].

HARRIS, WH ;

SALZMAN, EW ;

ATHANASOULIS, C ;

WALTMAN, AC ;

BAUM, S ;

DESANCTIS, RW .

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1974, A 56 (08) :1552-1562

[10]

HEY DM, 1972, 3 C THROMB INT SOC T, P426

← 1 2 3 →